Effect of Two Acupuncture Protocols on Vulvodynia
Acu/Vul-pain
Pilot Clinical Trial of Two Acupuncture Protocols on Vulvodynia
1 other identifier
interventional
51
1 country
1
Brief Summary
Vulvodynia is a common condition in women (16%); however, at this time there is no known effective non-pharmacological therapy reported. Acupuncture is one complementary and alternative medicine therapy used by many patients with vulvodynia; some case reports show that acupuncture may be an effective intervention. In recent years, there were some studies registered took at like at actual trials of acupuncture on vulvodynia, but either they did not reach the trial aims, some studies did not get enough patients or the trial designs mimic drug studies and did not reflect acupuncture real characteristics. This study evaluates acupuncture for the treatment of vulvodynia; specifically, if it reduces vulvar pain, pain duration and pain with intercourse. It also examines how long the effect of acupuncture lasts in women with vulvodynia. One third of the women will receive acupuncture focused on pudendal nerve distribution area; another one third of the women will receive acupuncture focused on traditional meridian points; the other one third of women will use standard care (without acupuncture). Women who get a reduction in pain (included in subjective and objective scores) will have their pain monitored once a week for up to 6 weeks to see if the acupuncture effect lasts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 8, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedSeptember 3, 2020
September 1, 2020
3 years
March 8, 2018
September 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Score (objective)
Figure out the pain score using Visual Analog pain scale(VAS) using cotton swab , \[score 0-no pain, 10-strongest (unbearable) pain\]. Expected clinical significant difference (ECSD): 3.
at the end of 6 weeks
Secondary Outcomes (3)
Pain Score (Subjective)
at the end of 6 weeks
Pain duration
at the end of 6 weeks
Intercourse pain
at the end of 6 weeks
Study Arms (3)
Group1a, Acupuncture on Vulvodynia
ACTIVE COMPARATORFocus on using the local points in pudendal nerve distribution area
Group1b, Acupuncture on Vulvodynia
ACTIVE COMPARATORFocus on traditional acupuncture using common meridian or distal points
Group2, Standard care or waiting lists
ACTIVE COMPARATORStandard care without acupuncture
Interventions
Needle size: #32(0.22 mm), 1-1.5 inch(30-40 mm long); Acupuncture time and frequency: 45 min per session, once or twice per week, for 6-12 sessions total (in 6 weeks).
PT, pain medications, nerve block, etc
Eligibility Criteria
You may qualify if:
- diagnosis of generalized vulvodynia or provoked vestibulodynia by OB/GYN doctor(s) or pain specialist(s); 18 to 45 years old.
- Current pain score 4 or higher with tampon insertion and removal performed, or cotton swab test, at the initial screening exam
- speak and read English or Chinese.
You may not qualify if:
- infectious conditions of the vulvar/vagina;
- inflammatory conditions of the vulvar/vagina;
- neoplastic disorders of the vulvar/vagina;
- neurologic disorders of the vulvar/vagina;
- acute trauma to the genitals;
- iatrogenic conditions of the genitals
- hormonal deficiencies
- co-morbid pelvic pain conditions (to avoid confounding pain outcomes) such as pelvic inflammatory disease and documented history of endometriosis
- menopause
- patients have active migraine headaches, temporomandibular joint disease (TMJ), irritable bowel syndrome (IBS), interstitial cystitis, painful bladder syndrome, or fibromyalgia, in past 6 month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McLean Center for Complementary and Alternative Medicine,PLC
Vienna, Virginia, 22182, United States
Related Publications (1)
Fan AY, Alemi SF, Zhu YH, Rahimi S, Wei H, Tian H, He D, Gong C, Yang G, He C, Ouyang H. Effectiveness of two different acupuncture strategies in patients with vulvodynia: Study protocol for a pilot pragmatic controlled trial. J Integr Med. 2018 Nov;16(6):384-389. doi: 10.1016/j.joim.2018.10.004. Epub 2018 Oct 10.
PMID: 30341023DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arthur Y Fan, MD(CHN),PhD
McLean Center for Complementary and Alternative Medicine, PLC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- All participants will get real treatments, the first group patients will get acupuncture treatments focus on the points within pudendal nerve distribution area; the second group patients will get acupuncture treatments focus on the points from traditional meridian theory. And the third group will get the standard care (no acupuncture). Participants and outcomes assessor will be blinded for the study aims.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director,Principal Investigator
Study Record Dates
First Submitted
March 8, 2018
First Posted
March 29, 2018
Study Start
January 1, 2018
Primary Completion
December 31, 2020
Study Completion
December 31, 2021
Last Updated
September 3, 2020
Record last verified: 2020-09